Strategies for discovering novel cancer biomarkers through utilization of emerging technologies

V Kulasingam, EP Diamandis - Nature clinical practice Oncology, 2008 - nature.com
The introduction of technologies such as mass spectrometry and protein and DNA arrays,
combined with our understanding of the human genome, has enabled simultaneous …

Human body fluid proteome analysis

S Hu, JA Loo, DT Wong - Proteomics, 2006 - Wiley Online Library
The focus of this article is to review the recent advances in proteome analysis of human
body fluids, including plasma/serum, urine, cerebrospinal fluid, saliva, bronchoalveolar …

Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I …

OJ Semmes, Z Feng, BL Adam, LL Banez… - Clinical …, 2005 - academic.oup.com
Background: Protein expression profiling for differences indicative of early cancer has
promise for improving diagnostics. This report describes the first stage of a National Cancer …

Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma

GR Thomas, H Nadiminti… - International journal of …, 2005 - Wiley Online Library
Head and neck squamous cell carcinoma (HNSCC) involves the upper aerodigestive tract
and can destroy the structure and function of organs involved in voice, speech, taste, smell …

Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry

JL Luque-Garcia, TA Neubert - Journal of Chromatography A, 2007 - Elsevier
In this article, we present an overview of the different strategies for sample preparation for
identification by mass spectrometry (MS) of biomarkers from serum and/or plasma. We …

Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma

AL Carvalho, C Jeronimo, MM Kim, R Henrique… - Clinical Cancer …, 2008 - AACR
Purpose: To evaluate aberrant promoter hypermethylation of candidate tumor suppressor
genes as a means to detect epigenetic alterations specific to solid tumors, including head …

Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry

JYMN Engwegen, MCW Gast, JHM Schellens… - Trends in …, 2006 - cell.com
Recently, the focus of cancer research has expanded from genetic information in the human
genome to protein expression analyses. Because this 'proteome'reflects the state of a cell …

Deciphering the role of HPV-mediated metabolic regulation in shaping the tumor microenvironment and its implications for immunotherapy in HNSCC

X Gong, J Xiong, Y Gong, J Zhang, J Zhang… - Frontiers in …, 2023 - frontiersin.org
Head and neck squamous cell carcinoma (HNSCC), as a complex and variable malignancy,
poses a significant threat to human health. Since the intricate association between HPV and …

Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer

G Malik, MD Ward, SK Gupta, MW Trosset… - Clinical cancer …, 2005 - AACR
Purpose: We recently showed that protein expression profiling of serum using surface-
enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) has …

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements

CM Sturgeon, BR Hoffman, DW Chan, SL Ch'ng… - 2008 - academic.oup.com
Background: This report presents updated National Academy of Clinical Biochemistry
Laboratory Medicine Practice Guidelines summarizing quality requirements for the use of …